CHARLENE SPARROW: Open Payments
NPI 1568868099 · CORDOVA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,805 in 91 payments from 16 companies in 2025. Trend: 2023 $686 · 2024 $1,132 · 2025 $1,805
Food & beverage: $1,805
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $250 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $201 |
| Vanda Pharmaceuticals Inc. | 7 | $182 |
| Otsuka America Pharmaceutical, Inc. | 10 | $156 |
| Supernus Pharmaceuticals, Inc. | 9 | $154 |
| Alkermes, Inc. | 6 | $154 |
| Janssen Pharmaceuticals, Inc | 7 | $139 |
| ABBVIE INC. | 5 | $131 |
| Axsome Therapeutics, Inc. | 6 | $106 |
| Collegium Pharmaceutical, Inc. | 4 | $81 |
Products named: CAPLYTA, REXULTI, TRINTELLIX, Qelbree, ARISTADA, SPRAVATO, HETLIOZ, VRAYLAR.
Industry payments across TN — which companies pay providers there.
